Business

The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab

Diana Brixner, RPh, PhD; Gary Oderda, PharmD, MPH; Joseph Biskupiak, PhD, MBA; Douglas S. Burgoyne, PharmD, FAMCP; Steven G. Avey, RPh, MS, FAMCP; Steven R. Feldman, MD, PhD

Business, Original Research

Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

Ken LaPensee, PhD, MPH; Thomas Lodise, PharmD, PhD

Stakeholder Perspective

Love the Models, Send Me My Data: Conceptual Healthcare Decision Models Informing the Treatment of Acute Bacterial Skin and Skin Structure Infections

Michael F. Murphy, MD, PhD

Business, Original Research

Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database

Richard A. Brook, MS, MBA; Krithika Rajagopalan, PhD; James E. Smeeding, RPh, MBA

Stakeholder Perspective

The Importance of Clinical and Economic Support Systems for Caregivers

Michael Kleinrock

Business, Original Research

Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients

Tia Goss Sawhney, DrPH, FSA, MAAA; Bruce S. Pyenson, FSA, MAAA; David Rotter, PhD; Michele Berrios; Judy Yee, MD

Business, Original Research

Alternative Payment Models in Medical Oncology: Assessing Quality-of-Care Outcomes Under Partial Capitation

Derek Ems, MPH; Sharanya Murty, PhD; Bryan Loy, MD; Judith Gallagher, MBA; Laura E. Happe, PharmD, MPH; Teresa L. Rogstad, MPH; Debra Finnel; Jimmy D. Fernandez, MD, MBA

Business, Original Research

Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes

Ivar S. Jensen, MBA; Elizabeth Wu, MPH; Naomi C. Sacks, PhD; Philip L. Cyr, MPH; Karen C. Chung, PharmD, MS

Business, Original Research

Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly

Sameer R. Ghate, PhD; Zhiyi Li, MBA, MA; Jackson Tang, MSc; Antonio Reis Nakasato, MD

Stakeholder Perspective

It’s About the Total Cost of Care

Gary M. Owens, MD

Business, Original Research

Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies

Vincent J. Willey, PharmD; Sheldon Kong, PhD; Bingcao Wu, MS; Amit Raval, PhD; Todd Hobbs, MD; Andrea Windsheimer, PharmD; Gaurav Deshpande, MS, PhD; Ozgur Tunceli, PhD; Brian Sakurada, PharmD; Jonathan R. Bouchard, MS, RPh

Business, Original Research

The Prevalence and Payer Costs of Potentially Avoidable Emergent Care Visits for Suspected Amniotic Membrane Rupture in Pregnant Women

Christine Ferro, CHFP; Bruce S. Pyenson, FSA, MAAA; Jocelyn Lau, MPH; Mona Kelkar, MBA; Nancy Phillips, MD; Chi-Wei Lu, PhD; Percy Yeung, PhD; Gloria Bachmann, MD

Stakeholder Perspective

Interventions to Reduce Avoidable Pregnancy-Related Emergency Department Visits

Eliza Ng, MD

Business, Original Research

Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn’s Disease

Michele Wilson, MSPH; Aaron Lucas, PhD, MPH; Ann Cameron, MA, PhD; Michelle Luo, PhD

Page 3 of 15
Results 21 - 30 of 145